{
    "accession": "ENCBS028RXB",
    "age": "4",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "insertion",
            "introduced_tags": [
                {
                    "location": "C-terminal",
                    "name": "eGFP"
                }
            ],
            "method": "CRISPR",
            "modified_site_by_target_id": "BNC2",
            "purpose": "tagging"
        }
    ],
    "biosample_term_id": "EFO:0003072",
    "biosample_term_name": "SK-N-SH",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/85612947-92e9-4bd2-94c2-93ff4964dc5b/@@download/attachment/ENCODE4_Snyder_CellGrowth_SK-N-SH_v1.pdf",
            "document_type": "growth protocol",
            "references": [],
            "urls": []
        },
        {
            "attachment": "/documents/143dc7d7-ecc7-4b0d-a80d-7a6861e4a228/@@download/attachment/ENCODE4_Snyder_CellTransfection_SK-N-SH_v2.pdf",
            "document_type": "transfection protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000ABD",
    "health_status": "Metastatic neuroblastoma from bone marrow",
    "lab": "Michael Snyder, Stanford",
    "life_stage": "child",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "Michael Snyder",
    "summary": "Homo sapiens SK-N-SH cell line genetically modified (insertion) using CRISPR targeting BNC2 treated with 6 \u03bcM all-trans-retinoic acid for 48 hours",
    "treatments": [
        {
            "dbxrefs": [],
            "duration": 48,
            "duration_units": "hour",
            "treatment_term_id": "CHEBI:15367",
            "treatment_term_name": "all-trans-retinoic acid",
            "treatment_type": "chemical"
        }
    ]
}